Kura Oncology expands 2014 equity incentive plan share reserve to 41,077,686 shares

• Kura Oncology updated its amended and restated 2014 equity incentive plan, keeping employees, directors, and consultants eligible for awards.
• The plan’s share reserve was set at 41,077,686 shares, including 6,500,000 shares added with stockholder approval at the 2026 annual meeting.
• Non-employee director pay was capped at USD 750,000 per annual period, rising to USD 1,000,000 for first-time directors.
• The plan limits option and SAR repricing, barring underwater cancellations for cash or new awards without stockholder approval within 12 months.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Kura Oncology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-257368), on June 04, 2026, and is solely responsible for the information contained therein.